ATE336576T1 - Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird - Google Patents

Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird

Info

Publication number
ATE336576T1
ATE336576T1 AT99203310T AT99203310T ATE336576T1 AT E336576 T1 ATE336576 T1 AT E336576T1 AT 99203310 T AT99203310 T AT 99203310T AT 99203310 T AT99203310 T AT 99203310T AT E336576 T1 ATE336576 T1 AT E336576T1
Authority
AT
Austria
Prior art keywords
image
trkb
oncogene
detection system
protein encoded
Prior art date
Application number
AT99203310T
Other languages
English (en)
Inventor
Stephen P Squinto
David J Glass
Thomas H Aldrich
Peter Distephano
Trevor Stitt
Marc E Furth
George D Yancopoulos
Peter C Maisonpierre
Piotr Masiakowski
Nancy Ip
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of ATE336576T1 publication Critical patent/ATE336576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99203310T 1991-04-23 1992-04-23 Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird ATE336576T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69019991A 1991-04-23 1991-04-23
US73655991A 1991-07-26 1991-07-26

Publications (1)

Publication Number Publication Date
ATE336576T1 true ATE336576T1 (de) 2006-09-15

Family

ID=27104557

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92912036T ATE214733T1 (de) 1991-04-23 1992-04-23 Nachweissystem für die neurotrophin-aktivität
AT99203310T ATE336576T1 (de) 1991-04-23 1992-04-23 Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT92912036T ATE214733T1 (de) 1991-04-23 1992-04-23 Nachweissystem für die neurotrophin-aktivität

Country Status (18)

Country Link
EP (2) EP0589961B1 (de)
JP (1) JPH06509413A (de)
AT (2) ATE214733T1 (de)
AU (1) AU676664B2 (de)
CA (1) CA2109100A1 (de)
CZ (1) CZ223793A3 (de)
DE (2) DE69233649D1 (de)
DK (1) DK0589961T3 (de)
ES (1) ES2170056T3 (de)
FI (1) FI934701L (de)
HU (1) HUT66051A (de)
IE (1) IE921316A1 (de)
IL (1) IL101661A (de)
NO (1) NO933819L (de)
NZ (1) NZ242468A (de)
PT (1) PT100423A (de)
SK (1) SK116593A3 (de)
WO (1) WO1992018149A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109598A1 (en) * 1991-05-21 1992-11-26 Finn Hallbook Therapeutic and diagnostic methods based on neurotrophin-4- expression
WO1993025684A1 (en) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Therapeutic and diagnostic methods based on neurotrophin-4 expression
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−３遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5625121A (en) * 1993-09-02 1997-04-29 Bristol-Myers Squibb Company Mice deficient in nerve growth factor receptors encoded by trkB
US5753225A (en) 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
EP0939829B1 (de) * 1996-03-28 2008-08-20 Trustees Of Boston University Methoden zur modulation der melaninsynthese
WO1997037228A1 (en) * 1996-03-29 1997-10-09 The Trustees Of Boston University Methods for diagnosing and treating alzheimer's disease
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
EP2789630A1 (de) 2013-04-09 2014-10-15 EngMab AG Bispezifische Antikörper gegen CD3e und ROR1
EP3204415B1 (de) 2014-10-09 2020-06-17 EngMab Sàrl Bispezifische antikörper gegen cd3epsilon und ror1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5231001A (en) * 1991-03-14 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
CA2062377A1 (en) * 1991-03-21 1992-09-22 Mariano Barbacid Method for detection of neuroactive substances
US5843749A (en) * 1991-07-26 1998-12-01 Regeneron Pharmaceuticals, Inc. Ehk and Ror tyrosine kinases

Also Published As

Publication number Publication date
NO933819D0 (no) 1993-10-22
JPH06509413A (ja) 1994-10-20
EP1001024B1 (de) 2006-08-16
FI934701A7 (fi) 1993-12-22
IL101661A (en) 1998-02-08
ES2170056T3 (es) 2002-08-01
FI934701L (fi) 1993-12-22
ATE214733T1 (de) 2002-04-15
EP1001024A3 (de) 2004-02-18
IL101661A0 (en) 1992-12-30
NO933819L (no) 1993-12-20
IE921316A1 (en) 1992-11-04
DK0589961T3 (da) 2002-05-27
EP1001024A2 (de) 2000-05-17
CZ223793A3 (en) 1994-08-17
WO1992018149A1 (en) 1992-10-29
HUT66051A (en) 1994-09-28
HU9303012D0 (en) 1994-03-28
DE69232496D1 (de) 2002-04-25
DE69232496T2 (de) 2002-10-10
EP0589961A1 (de) 1994-04-06
CA2109100A1 (en) 1992-10-29
HK1024935A1 (en) 2000-10-27
EP0589961A4 (de) 1994-11-02
NZ242468A (en) 1994-12-22
EP0589961B1 (de) 2002-03-20
FI934701A0 (fi) 1993-10-25
AU2014992A (en) 1992-11-17
PT100423A (pt) 1993-08-31
AU676664B2 (en) 1997-03-20
SK116593A3 (en) 1994-11-09
DE69233649D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
ATE336576T1 (de) Durch das trkb proto-onkogen kodiertes protein, das als nachweissystem für die neurotrophin- aktivität gebraucht wird
DK0842273T3 (da) Receptorligand VGEF-C
EP0727212A3 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
DK0429612T3 (da) Fremgangsmåde til optisk analyse
WO1997021811A3 (en) Novel tyrosine kinase receptors and ligands
FI964862L (fi) FLT4-reseptorityrosiinikinaasi ja sen käyttö diagnostiikassa ja terapiassa
DE69001972D1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
DE69012485D1 (de) Zweispektrumsabbildung- und Falschfarben-Darstellungssystem.
EP0634016A4 (de) Qualitätskontrolle für analytische verfahren.
FR2706484B1 (fr) Polypeptide mutant de la protéine kinase C, séquences d'acides nucléiques codant pour ledit polypeptide et leurs utilisations.
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE58902270D1 (de) Atemanalysesystem.
FI925457A0 (fi) Receptor av den ciliaera neurotrofiska faktorn
WO1999033967A3 (en) Novel nucleic acid and polypeptide with homology to the tnf-receptors
DE69434498D1 (de) Denervierende muskelkinase (dmk), ein rezeptor der tyrosinkinase-superfamilie
FR2655835B1 (fr) Appareil de detection de kystes et/ou tumeurs du sein.
EP1575515A4 (de) Achaete-scute-ähnliche 2 polypeptide und kodierende nukleinsäuren und verfahren zur diagnose und behandlung eines tumors
CA2288080A1 (en) Method for the functional detection of disorders in the protein c system
WO1996037610A3 (en) Cck-4, a receptor tyrosine kinase, and methods for diagnosis and treatment of cck-4 signal transduction disorders
ITRM930002A0 (it) Antibiogramma e corredo diagnostico per la sua realizzazione.
FR2705234B1 (fr) Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
ATE148231T1 (de) Testsystem für degenerative muskelerkrankungen
FR2686704B1 (fr) Procede et systeme de test du fonctionnement et/ou de la presence d'elements connectes en parallele.
NZ238281A (en) Ciliary neurotrophic factor receptor (cntf), its use, detection, diagnostic techniques and assay systems
IT225224Z2 (it) Pedana estraibile composta da due gradini per campers e veicoli vari.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties